Arrestin Pathways as Drug Targets - Progress in Molecular Biology and Translational Science - page 481

94. Richardson RM, Marjoram RJ, Barak LS, Snyderman R. Role of the cytoplasmic tails
of CXCR1 and CXCR2 in mediating leukocyte migration, activation and regulation.
J Immunol . 2003;170:2904 - 2911.
95. Colvin RA, Campanella GS, Sun J, Luster AD. Intracellular domains of CXCR3 that
mediate CXCL9, CXCL10, and CXCL11 function. J Biol Chem . 2004;279:

30219- 30227.
96. Sun Y, Cheng Z, Ma L, Pei G. Beta-arrestin2 is critically involved in CXCR4-
mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activa-
tion. J Biol Chem . 2002;277:49212- 49219.
97. Lagane B, Ballet S, Planchenault T, et al. Mutation of the DRY motif reveals different
structural requirements for the CC chemokine receptor 5-mediated signaling and
receptor endocytosis. Mol Pharmacol . 2005;67:1966 - 1976.
98. Witherow DS, Garrison TR, Miller WE, Lefkowitz RJ. beta-Arrestin inhibits
NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor
IkappaBalpha. Proc Natl Acad Sci USA . 2004;101:8603- 8607.
99. Luan B, Zhang Z, Wu Y, Kang J, Pei G. Beta-arrestin2 functions as a phosphorylation-
regulated suppressor of UV-induced NF-kappaB activation. EMBO J . 2005;24:
4237- 4246.
100. Gao H, Sun Y, Wu Y, et al. Identification of beta-arrestin2 as a G protein-coupled
receptor-stimulated regulator of NF-kappaB pathways. Mol Cell . 2004;14:303- 317.
101. Basher F, Fan H, Zingarelli B, et al. beta-Arrestin 2: a negative regulator of inflamma-
tory responses in polymorphonuclear leukocytes. Int J Clin Exp Med . 2008;1:32- 41.
102. Walker JK, Fong AM, Lawson BL, et al. Beta-arrestin-2 regulates the development of
allergic asthma. J Clin Invest . 2003;112:566 - 574.
103. Su Y, Raghuwanshi SK, Yu Y, Nanney LB, Richardson RM, Richmond A. Altered
CXCR2 signaling in b -arrestin-2-deficient mouse models. J Immunol . 2005;

175:5396- 5402.